Immutep’S Efti With Radiotherapy & KEYTRUDA® Meets Primary Endpoint In Phase 2 For Soft Tissue Sarcoma

RefinitivMenos de 1 minuto de leitura

Immutep Ltd IMM:

IMMUTEP’S EFTI WITH RADIOTHERAPY & KEYTRUDA® (PEMBROLIZUMAB) MEETS PRIMARY ENDPOINT IN PHASE II FOR SOFT TISSUE SARCOMA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Entrar ou criar uma conta gratuita para ler essa notícia